« Return to News | CROs/Service Providers

Spaulding, Frontage partner in clinical development

Tuesday, September 13, 2011 01:37 PM

Spaulding Clinical Research, the US-based provider of clinical pharmacology and cardiac core-laboratory services is extending its reach further east through an alliance with Frontage Laboratories, according to PharmaTimes.

Under the strategic partnership agreement, Spaulding will conduct all intense electrocardiographic (ECG) studies on behalf of Frontage at its US clinical pharmacology unit in West Bend, Wisconsin as well as providing ECG Core Lab services for its partner.

Frontage, a full-service clinical research organization with facilities in the US and China, will in return offer bioanalytical method development and sample processing, formulation development and clinical trial product supplies on Spaulding’s behalf while serving as one of the clinical sites for Spaulding Clinical clients in China.

Randy Spaulding, chief executive officer and founder of Spaulding Clinical, said the collaboration was “another step forward in meeting our strategic objectives of providing the highest quality global clinical development facilities to our clients interested in accelerating drug development. Together, Frontage and Spaulding Clinical will deliver the first US-based fully-automated Clinical Pharmacology unit in China.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.